MAKO Surgical Narrows Loss in Q1

MAKO Surgical's (UNKNOWN: MAKO.DL  ) Q1 results show a smaller loss. For the quarter, revenue was $24.8 million, a notable rise from the $19.6 million in the same period the previous year. The company managed to thin its net loss, which came in at $9.6 million ($0.21 per diluted share) from Q1 2012's shortfall of $11.7 million ($0.28).

MAKO Surgical made most its money by selling five of its Robotic Arm Interactive Orthopedic platforms and reaping the revenue from nearly 3,000 of its MAKOplasty orthopedic surgery procedures.

Analysts had been expecting revenue of $24.4 million and a per-share loss of $0.19.

The company also reiterated its prior guidance. It still expects to sell 45 to 48 RIO Systems this year and anticipates that 13,500-14,500 MAKOplasty procedures will be performed.

Read/Post Comments (3) | Recommend This Article (6)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

  • Report this Comment On May 07, 2013, at 10:20 PM, Dawgpac wrote:

    I was pleasantly surprised that they only burned through a net of $2M cash in Q1. Ended Q1 with $73M vs $75M at end of Q4 2012. Zero debt on the books and indicated they will pay an inactivity fee and allow the Deerfield Line of Credit to expire untapped.

  • Report this Comment On May 08, 2013, at 3:16 AM, TMFVolkman wrote:

    Dawgpac, I agree that it's impressive. Particularly for a company involved in a sector that can really drain capital.

  • Report this Comment On May 08, 2013, at 11:41 AM, msb09 wrote:

    Dawgpac, also agree. Especially since 1 million dollars spent on buying the patents from Stanmore. Recent positive publications and educational conferences continue to highlight the benefits of MAKO.

Add your comment.

Compare Brokers

Fool Disclosure

Sponsored Links

Leaked: Apple's Next Smart Device
(Warning, it may shock you)
The secret is out... experts are predicting 458 million of these types of devices will be sold per year. 1 hyper-growth company stands to rake in maximum profit - and it's NOT Apple. Show me Apple's new smart gizmo!

DocumentId: 2415995, ~/Articles/ArticleHandler.aspx, 9/30/2016 11:32:31 PM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...

Today's Market

updated 2 hours ago Sponsored by:
DOW 18,308.15 164.70 0.91%
S&P 500 2,168.27 17.14 0.80%
NASD 5,312.00 42.85 0.81%

Create My Watchlist

Go to My Watchlist

You don't seem to be following any stocks yet!

Better investing starts with a watchlist. Now you can create a personalized watchlist and get immediate access to the personalized information you need to make successful investing decisions.

Data delayed up to 5 minutes

Related Tickers

12/31/1969 7:00 PM
MAKO.DL $0.00 Down +0.00 +0.00%
MAKO Surgical CAPS Rating: ****